RSK inhibition or silencing of RSK1 and/or RSK2 reduce cellular proliferation, survival, migration, invasion, cancer stem cell growth, and tumor growth, preferentially in TNBC cell lines [6–13]. The gene discussed is RPS6KA2; the disease is neoplasm.